株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

インスリン・デリバリー装置:パイプライン分析

Insulin Delivery - Pipeline Review, 2015

発行 GlobalData 商品コード 227854
出版日 ページ情報 英文 196 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
インスリン・デリバリー装置:パイプライン分析 Insulin Delivery - Pipeline Review, 2015
出版日: 2015年05月25日 ページ情報: 英文 196 Pages
担当者のコメント
インスリン・ペンのデータが不要の場合は 商品コード:224429 のレポートを御選択ください。
概要

当レポートでは、世界各国の企業・医療機関などで開発中のインスリン・デリバリー装置 (インスリン送達装置) のパイプライン製品情報について分析し、治験/製品開発の全体的な進行状況や、段階別・地域別・分野別の詳細動向、企業別・製品別の詳細情報 (治験の進行段階、開始/終了時期、認証見通しなど)、昨今の開発・資本取引の動きなどを盛り込んでお届けいたします。

第1章 目次

第2章 イントロダクション

  • インスリン・デリバリー装置の概要

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:認証時期別 (推定)
  • 現在進行中の治験

第4章 インスリン・デリバリー装置:開発中のパイプライン製品 (企業別)

  • インスリン・デリバリー装置の開発企業:開発段階別のパイプライン製品
  • インスリン・デリバリー装置:開発段階別のパイプライン製品

第5章 インスリン・デリバリー装置の開発企業・製品の概要

  • Amrita Vishwa Vidyapeetham:企業概要
    • パイプライン製品および進行中の治験の概要
  • Andain, Inc:企業概要
  • AstraZeneca PLC:企業概要
  • Becton, Dickinson and Company:企業概要
  • Cellnovo Ltd.:企業概要
  • CeQur SA:企業概要
  • Companion Medical:企業概要
  • ConvaTec Healthcare B S.a.r.l.:企業概要
  • Dance Biopharm Inc.:企業概要
  • Debiotech S.A.:企業概要
  • InsuLenz:企業概要
  • Insulet Corporation:企業概要
  • InsuLine Medical Ltd.:企業概要
  • LifeScan, Inc.:企業概要
  • Medical International Technologies (Mit Canada) Inc.:企業概要
  • MedSolve Technologies, Inc.:企業概要
  • MicroPort Scientific Corporation:企業概要
  • North Carolina State University:企業概要
  • Sanofi:企業概要
  • SFC Fluidics LLC:企業概要
  • Spring Health Solutions Ltd.:企業概要
  • Transdermal Specialties, Inc.:企業概要
  • University of KwaZulu-Natal:企業概要
  • University of Toronto:企業概要
  • Ypsomed Holding AG:企業概要

第6章 昨今の動向

第7章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0011EPD

GlobalData's Medical Devices sector report, "Insulin Delivery - Pipeline Review, 2015" provides an overview of Insulin Delivery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Insulin Delivery pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Insulin Delivery products under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Insulin Delivery and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Insulin Delivery under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Insulin Delivery Overview

3. Products under Development

  • 3.1. Insulin Delivery - Pipeline Products by Stage of Development
  • 3.2. Insulin Delivery - Pipeline Products by Segment
  • 3.3. Insulin Delivery - Pipeline Products by Territory
  • 3.4. Insulin Delivery - Pipeline Products by Regulatory Path
  • 3.5. Insulin Delivery - Pipeline Products by Estimated Approval Date
  • 3.6. Insulin Delivery - Ongoing Clinical Trials

4. Insulin Delivery - Pipeline Products under Development by Companies

  • 4.1. Insulin Delivery Companies - Pipeline Products by Stage of Development
  • 4.2. Insulin Delivery - Pipeline Products by Stage of Development

5. Insulin Delivery Companies and Product Overview

  • 5.1. Amrita Vishwa Vidyapeetham Company Overview
    • 5.1.1. Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Andain, Inc Company Overview
    • 5.2.1. Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. AstraZeneca PLC Company Overview
    • 5.3.1. AstraZeneca PLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Becton, Dickinson and Company Company Overview
    • 5.4.1. Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Cellnovo Ltd. Company Overview
    • 5.5.1. Cellnovo Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. CeQur SA Company Overview
    • 5.6.1. CeQur SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Companion Medical Company Overview
    • 5.7.1. Companion Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. ConvaTec Healthcare B S.a.r.l. Company Overview
    • 5.8.1. ConvaTec Healthcare B S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Dance Biopharm Inc. Company Overview
    • 5.9.1. Dance Biopharm Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Debiotech S.A. Company Overview
    • 5.10.1. Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. InsuLenz Company Overview
    • 5.11.1. InsuLenz Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Insulet Corporation Company Overview
    • 5.12.1. Insulet Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. InsuLine Medical Ltd. Company Overview
    • 5.13.1. InsuLine Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. LifeScan, Inc. Company Overview
    • 5.14.1. LifeScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Medical International Technologies (Mit Canada) Inc. Company Overview
    • 5.15.1. Medical International Technologies (Mit Canada) Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. MedSolve Technologies, Inc. Company Overview
    • 5.16.1. MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. MicroPort Scientific Corporation Company Overview
    • 5.17.1. MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. North Carolina State University Company Overview
    • 5.18.1. North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Sanofi Company Overview
    • 5.19.1. Sanofi Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. SFC Fluidics LLC Company Overview
    • 5.20.1. SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Spring Health Solutions Ltd. Company Overview
    • 5.21.1. Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Transdermal Specialties, Inc. Company Overview
    • 5.22.1. Transdermal Specialties, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. University of KwaZulu-Natal Company Overview
    • 5.23.1. University of KwaZulu-Natal Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. University of Toronto Company Overview
    • 5.24.1. University of Toronto Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Ypsomed Holding AG Company Overview
    • 5.25.1. Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview

6. Insulin Delivery- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Insulin Delivery - Pipeline Products by Stage of Development
  • Table 2: Insulin Delivery - Pipeline Products by Segment
  • Table 3: Insulin Delivery - Pipeline Products by Territory
  • Table 4: Insulin Delivery - Pipeline Products by Regulatory Path
  • Table 5: Insulin Delivery - Pipeline Products by Estimated Approval Date
  • Table 6: Insulin Delivery - Ongoing Clinical Trials
  • Table 7: Insulin Delivery Companies - Pipeline Products by Stage of Development
  • Table 8: Insulin Delivery - Pipeline Products by Stage of Development
  • Table 9: Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: MEMS-based Insulin Pump - Product Status
  • Table 11: MEMS-based Insulin Pump - Product Description
  • Table 12: Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Gaia Med Diamond Insulin Pump - Product Status
  • Table 14: Gaia Med Diamond Insulin Pump - Product Description
  • Table 15: Miniature Insulin Pump - Product Status
  • Table 16: Miniature Insulin Pump - Product Description
  • Table 17: AstraZeneca PLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: BYDUREON Dual Chamber Pen - Product Status
  • Table 19: BYDUREON Dual Chamber Pen - Product Description
  • Table 20: Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: BD FlowSmart Infusion Set - Product Status
  • Table 22: BD FlowSmart Infusion Set - Product Description
  • Table 23: Cellnovo Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Cellnovo Wireless Insulin Pump System - Product Status
  • Table 25: Cellnovo Wireless Insulin Pump System - Product Description
  • Table 26: CeQur SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: PaQ Insulin Delivery Device - Product Status
  • Table 28: PaQ Insulin Delivery Device - Product Description
  • Table 29: CeQur SA - Ongoing Clinical Trials Overview
  • Table 30: PaQ Insulin Delivery Device - A Prospective, Single Center Study to Assess the Performance, Safety, and Patient Reported Outcomes of Insulin Delivery With PaQ in Patients With Type 2 Diabetes Mellitus
  • Table 31: PaQ Insulin Delivery Device - A Prospective, Single Center, Post-Market Observational Study to Assess the Efficacy, Safety and Patient Reported Outcomes of Insulin Delivery With PaQ in Patients With Type 2 Diabetes Mellitus
  • Table 32: Companion Medical Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Insulin Pen - Product Status
  • Table 34: Insulin Pen - Product Description
  • Table 35: ConvaTec Healthcare B S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Patch Pump - Product Status
  • Table 37: Patch Pump - Product Description
  • Table 38: Dance Biopharm Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Dance 501 - Product Status
  • Table 40: Dance 501 - Product Description
  • Table 41: Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Integrated iSense CGM And JewelPUMP - Product Status
  • Table 43: Integrated iSense CGM And JewelPUMP - Product Description
  • Table 44: Jewel Pump - Product Status
  • Table 45: Jewel Pump - Product Description
  • Table 46: JewelPUMP2 - Product Status
  • Table 47: JewelPUMP2 - Product Description
  • Table 48: Debiotech S.A. - Ongoing Clinical Trials Overview
  • Table 49: Jewel Pump - Feasibility Study of the JewelPump Version 3
  • Table 50: InsuLenz Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Smart Polymer Contact Lens - Product Status
  • Table 52: Smart Polymer Contact Lens - Product Description
  • Table 53: Insulet Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: OmniPod - New Version - Product Status
  • Table 55: OmniPod - New Version - Product Description
  • Table 56: InsuLine Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: InsuPad - Product Status
  • Table 58: InsuPad - Product Description
  • Table 59: InsuPatch Device - Product Status
  • Table 60: InsuPatch Device - Product Description
  • Table 61: InsuLine Medical Ltd. - Ongoing Clinical Trials Overview
  • Table 62: InsuPatch Device - Effect of the Insupatch on Automated Closed-loop Glucose Control in Type 1 Diabetes
  • Table 63: InsuPatch Device - Warming up to Sensors: Does Site Warming Improve Continuous Glucose Monitor Performance
  • Table 64: InsuPad - Evaluation of the Effects of Heating the Vicinity of the Insulin Delivery Site by the Experimental Device
  • Table 65: LifeScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 66: 3-Day Wearable Insulin Patch - Product Status
  • Table 67: 3-Day Wearable Insulin Patch - Product Description
  • Table 68: ONETOUCH Ping Verio Insulin Pump With Meter Remote - Product Status
  • Table 69: ONETOUCH Ping Verio Insulin Pump With Meter Remote - Product Description
  • Table 70: Medical International Technologies (Mit Canada) Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 71: MIT-P-I - Product Status
  • Table 72: MIT-P-I - Product Description
  • Table 73: MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 74: Freehand Patch Pump - Product Status
  • Table 75: Freehand Patch Pump - Product Description
  • Table 76: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 77: La Fenice Pen - Product Status
  • Table 78: La Fenice Pen - Product Description
  • Table 79: La Fenice V - Product Status
  • Table 80: La Fenice V - Product Description
  • Table 81: North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 82: Pulsatile Noninvasive Drug Delivery System - Product Status
  • Table 83: Pulsatile Noninvasive Drug Delivery System - Product Description
  • Table 84: Sanofi Pipeline Products & Ongoing Clinical Trials Overview
  • Table 85: Fix-Flex Device - Product Status
  • Table 86: Fix-Flex Device - Product Description
  • Table 87: SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 88: Disposable Insulin Patch Pump - Product Status
  • Table 89: Disposable Insulin Patch Pump - Product Description
  • Table 90: Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 91: Spring Zone Hybrid Patch Pump - Product Status
  • Table 92: Spring Zone Hybrid Patch Pump - Product Description
  • Table 93: Transdermal Specialties, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 94: U-Strip Insulin Patch - Product Status
  • Table 95: U-Strip Insulin Patch - Product Description
  • Table 96: University of KwaZulu-Natal Pipeline Products & Ongoing Clinical Trials Overview
  • Table 97: Pectin Insulin Gel Skin Patch - Product Status
  • Table 98: Pectin Insulin Gel Skin Patch - Product Description
  • Table 99: University of Toronto Pipeline Products & Ongoing Clinical Trials Overview
  • Table 100: Implantable Closed-Loop Insulin Delivery Device - Product Status
  • Table 101: Implantable Closed-Loop Insulin Delivery Device - Product Description
  • Table 102: Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 103: Lanzi - Product Status
  • Table 104: Lanzi - Product Description
  • Table 105: mylife YpsoPump - Product Status
  • Table 106: mylife YpsoPump - Product Description
  • Table 107: Glossary

List of Figures

  • Figure 1: Insulin Delivery - Pipeline Products by Stage of Development
  • Figure 2: Insulin Delivery - Pipeline Products by Segment
  • Figure 3: Insulin Delivery - Pipeline Products by Territory
  • Figure 4: Insulin Delivery - Pipeline Products by Regulatory Path
  • Figure 5: Insulin Delivery - Pipeline Products by Estimated Approval Date
  • Figure 6: Insulin Delivery - Ongoing Clinical Trials
Back to Top